Progyny, Inc. (NASDAQ:PGNY) Position Raised by Cetera Trust Company N.A

Cetera Trust Company N.A increased its position in shares of Progyny, Inc. (NASDAQ:PGNY) by 30.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,210 shares of the company’s stock after purchasing an additional 1,665 shares during the period. Cetera Trust Company N.A’s holdings in Progyny were worth $121,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PGNY. Wellington Management Group LLP bought a new position in shares of Progyny in the fourth quarter valued at $14,608,000. Vanguard Group Inc. increased its holdings in shares of Progyny by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 8,270,153 shares of the company’s stock valued at $307,484,000 after buying an additional 112,549 shares in the last quarter. Financial Management Professionals Inc. bought a new position in shares of Progyny in the first quarter valued at $52,000. Congress Wealth Management LLC DE increased its holdings in shares of Progyny by 27.4% in the first quarter. Congress Wealth Management LLC DE now owns 150,319 shares of the company’s stock valued at $5,735,000 after buying an additional 32,344 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its stake in Progyny by 9.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,260 shares of the company’s stock valued at $239,000 after purchasing an additional 543 shares during the period. Institutional investors own 94.93% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on PGNY. Leerink Partners cut their target price on shares of Progyny from $25.00 to $21.00 and set a “market perform” rating on the stock in a research note on Thursday, September 19th. Jefferies Financial Group lowered their price target on shares of Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 price target on shares of Progyny in a report on Tuesday, October 1st. JMP Securities cut shares of Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. Finally, BTIG Research cut shares of Progyny from a “buy” rating to a “neutral” rating in a report on Wednesday, August 7th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $27.73.

Progyny Trading Down 0.6 %

Progyny stock traded down $0.10 on Tuesday, reaching $16.25. 232,546 shares of the stock were exchanged, compared to its average volume of 1,369,270. The stock has a market cap of $1.55 billion, a PE ratio of 26.64, a PEG ratio of 1.48 and a beta of 1.43. Progyny, Inc. has a twelve month low of $13.93 and a twelve month high of $42.08. The firm has a fifty day moving average price of $19.76 and a two-hundred day moving average price of $25.62.

Progyny (NASDAQ:PGNY) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.17 EPS for the quarter, meeting analysts’ consensus estimates of $0.17. The business had revenue of $304.09 million during the quarter, compared to analyst estimates of $305.32 million. Progyny had a net margin of 5.54% and a return on equity of 11.97%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.15 earnings per share. Equities analysts anticipate that Progyny, Inc. will post 0.64 EPS for the current fiscal year.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.